Literature DB >> 22950551

Balanced prescribing - principles and challenges.

Jeffrey K Aronson1.   

Abstract

Balanced prescribing is a process that recommends a medicine appropriate to the patient's condition and, within the limits created by the uncertainty that attends therapeutic decisions, a dosage regimen that optimizes the balance of benefit to harm. The essential steps in achieving this are (a) careful attention to the history, examination, and investigation of the patient's condition and drug therapy, (b) accurate diagnosis, (c) detailed attention to prescribing the dosage regimen in the light of the therapeutic goal, (d) careful writing of the prescription and (e) regular monitoring of therapy, including attention to beneficial outcomes, adverse reactions, and patient adherence. The two major requirements in determining the dosage regimen are (1) understanding the pathophysiology of a health problem and matching it to the mechanisms of action of the relevant medicines and (2) assessing the benefit to harm balance of the therapy, although the difficulties in doing this in the individual are great. Major challenges in prescribing include provision of adequate education for all prescribers early in their undergraduate training and maintaining their expertise after graduation, obtaining evidence to inform appropriate monitoring of therapy, reducing the incidence of medication errors, and providing high quality information that will at the same time guide prescribing decisions and be sufficiently flexible to allow prescribers to tailor therapy to the needs of the individual patient. Careful attention to all facets of prescribing can improve the chances of benefit, reduce the risks of adverse reactions and interactions, and enhance adherence to therapy.
© 2012 The Author. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2012        PMID: 22950551      PMCID: PMC3477323          DOI: 10.1111/j.1365-2125.2012.04413.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Development and delivery of clinical pharmacology in regulatory agencies.

Authors:  Alasdair Breckenridge
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  From undergraduate medical education to pre-registration house officer year: how prepared are students?

Authors:  David Wall; Andrea Bolshaw; Justine Carolan
Journal:  Med Teach       Date:  2006-08       Impact factor: 3.650

3.  Balanced prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

4.  Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates.

Authors:  Amy Heaton; David J Webb; Simon R J Maxwell
Journal:  Br J Clin Pharmacol       Date:  2008-07       Impact factor: 4.335

5.  How well prepared are medical students for their first year as doctors? The views of consultants and specialist registrars in two teaching hospitals.

Authors:  C Matheson; D Matheson
Journal:  Postgrad Med J       Date:  2009-11       Impact factor: 2.401

6.  Pilot of a National Inpatient Medication Chart in Australia: improving prescribing safety and enabling prescribing training.

Authors:  Ian D Coombes; Carol Reid; David McDougall; Danielle Stowasser; Margaret Duiguid; Charles Mitchell
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

7.  Medication errors: the importance of an accurate drug history.

Authors:  Richard J Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335

8.  Impact of a standard medication chart on prescribing errors: a before-and-after audit.

Authors:  I D Coombes; D A Stowasser; C Reid; C A Mitchell
Journal:  Qual Saf Health Care       Date:  2009-12

Review 9.  Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Authors:  Su Golder; Yoon K Loke; Martin Bland
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

10.  A framework for taking a treatment history.

Authors:  A Herxheimer
Journal:  J R Coll Physicians Lond       Date:  1989-01
View more
  7 in total

1.  Doctors' perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study.

Authors:  Shane Cullinan; Aoife Fleming; Denis O'Mahony; Cristin Ryan; David O'Sullivan; Paul Gallagher; Stephen Byrne
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

2.  Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients.

Authors:  Andrew Frazer; James Rowland; Alison Mudge; Michael Barras; Jennifer Martin; Peter Donovan
Journal:  Eur J Clin Pharmacol       Date:  2019-09-11       Impact factor: 2.953

Review 3.  Design and delivery of a tailored intervention to implement recommendations for multimorbid patients receiving polypharmacy into primary care practices.

Authors:  Cornelia Jäger; Joachim Szecsenyi; Jost Steinhäuser
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

4.  The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin.

Authors:  Kanika Anand; Ingrid Sketris; Ying Zhang; Adrian Levy; John-Michael Gamble
Journal:  Drugs Real World Outcomes       Date:  2017-12

5.  Microbiologic characterisation of bacterial infections in children with atopic dermatitis.

Authors:  Nkosinathi O Zwane; Josiah T Masuka; Antoinette V Chateau; Anisa Mosam
Journal:  S Afr J Infect Dis       Date:  2022-03-31

6.  Prescribing issues in older adults living with HIV: thinking beyond drug-drug interactions with antiretroviral drugs.

Authors:  Françoise Livio; Catia Marzolini
Journal:  Ther Adv Drug Saf       Date:  2019-10-03

7.  Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies.

Authors:  Bernadette Clara Francisca Maria Schutijser; Irene Jongerden; Joanna Ewa Klopotowska; Marco Moesker; Maaike Langelaan; Cordula Wagner; Martine de Bruijne
Journal:  BMJ Open       Date:  2020-09-30       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.